Show simple item record

dc.contributor TÁMOP:4.2.1/B 09/1/KMR-2010-0001
dc.contributor TéT:-SIN
dc.contributor OTKA:83803
dc.contributor MTA Bolyai pályázat:
dc.contributor.author Szepes M,
dc.contributor.author Benkő, Zsolt
dc.contributor.author Cselenyák, Attila
dc.contributor.author Kompisch KM,
dc.contributor.author Schumacher U,
dc.contributor.author Lacza, Zsombor
dc.contributor.author Kiss, Levente
dc.date.accessioned 2015-11-22T12:23:29Z
dc.date.available 2015-11-22T12:23:29Z
dc.date.issued 2013
dc.identifier 84880170834
dc.identifier.citation pagination=178346; journalVolume=2013; journalTitle=STEM CELLS INTERNATIONAL;
dc.identifier.uri http://repo.lib.semmelweis.hu//handle/123456789/2493
dc.identifier.uri doi:10.1155/2013/178346
dc.description.abstract Regenerative therapies hold a promising and exciting future for the cure of yet untreatable diseases, and mesenchymal stem cells are in the forefront of this approach. However, the relative efficacy and the mechanism of action of different types of mesenchymal stem cells are still incompletely understood. We aimed to evaluate the effects of human adipose- (hASC) and bone-marrow-derived stem cells (hBMSCs) and adipose-derived stem cell conditioned media (ACM) on the viability of cardiomyoblasts in an in vitro ischemia-reperfusion (I-R) model. Flow cytometric viability analysis revealed that both cell treatments led to similarly increased percentages of living cells, while treatment with ACM did not (I-R model: 12.13 +/- 0.75%; hASC: 24.66 +/- 2.49%; hBMSC: 25.41 +/- 1.99%; ACM: 13.94 +/- 1.44%). Metabolic activity measurement (I-R model: 0.065 +/- 0.033; hASC: 0.652 +/- 0.089; hBMSC: 0.607 +/- 0.059; ACM: 0.225 +/- 0.013; arbitrary units) and lactate dehydrogenase assay (I-R model: 0.225 +/- 0.006; hASC: 0.148 +/- 0.005; hBMSC: 0.146 +/- 0.004; ACM: 0.208 +/- 0.009; arbitrary units) confirmed the flow cytometric results while also indicated a slight beneficial effect of ACM. Our results highlight that mesenchymal stem cells have the same efficacy when used directly on postischemic cells, and differences found between them in preclinical and clinical investigations are rather related to other possible causes such as their immunomodulatory or angiogenic properties.
dc.relation.ispartof urn:issn:1687-966X
dc.title Comparison of the direct effects of human adipose- and bone-marrow-derived stem cells on postischemic cardiomyoblasts in an in vitro simulated ischemia-reperfusion model.
dc.type Journal Article
dc.date.updated 2015-11-22T12:22:36Z
dc.language.rfc3066 en
dc.identifier.mtmt 2471538
dc.identifier.wos 000323839600001
dc.identifier.pubmed 23853609
dc.contributor.department SE/AOK/I/Klinikai Kísérleti Kutató- és Humán Élettani Intézet
dc.contributor.institution Semmelweis Egyetem


Files in this item

xmlui.dri2xhtml.METS-1.0.onlyFromAllowedIP

View/Open

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account